James J. Hsieh, MD, discusses differential overall survival (OS) results of the RECORD-3 study based on 3 distinct mRCC molecular subgroups, classified by patients who harbored <em>BAP1</em> and/or <em>PBRM1</em> mutations.
Ginny Vachon, PhD
Articles by Ginny Vachon, PhD
Latest Updated Articles
RECORD-3 Study Identifies Poor-Risk Patients With mRCCPublished: December 9th 2016 | Updated: